Cuba works to solve shortages of medicines

The Ministry of Public Health (Minsap) and the Group of Biotechnology and Pharmaceutical Industries (BioCubaFarma), among other organizations, develop actions eliminate the shortages of medicines in the country that started last year.

Autor:

Juventud Rebelde

HAVANA, Cuba, Nov  30 (ACN) The Ministry of Public Health (Minsap) and the Group of Biotechnology and Pharmaceutical Industries (BioCubaFarma), among other organizations, develop actions eliminate the shortages of medicines in the country that started last year.
 
During a press conference held by officials of those institutions, they said shortages happened due to the financial limitations the country faces, caused by the economic, commercial and financial blockade that for more than 50 years the United States keeps against Cuba.
 
The Master in Sciences Rita María García Almaguer, Director of Operations and Technology of BioCubaFarma, said that this critical situation did not allow them to pay suppliers to execute the agreed deliveries, that there were modifications in the forms of payment and with this a hike in the prices, and in other cases the non-offer of raw materials and packaging materials.
 
In addition, the effects of this genocidal policy cause high costs due to the impossibility to use dollars in transactions, difficulties with banks, having to use third countries to acquire equipment, American-made spare parts, reagents and other supplies, and obtain raw materials in very distant markets with long delivery periods, she explained.
 
This means having to spend more foreign currency than any other country would spend in order to obtain them, she stressed.
 
Among the actions implemented to reverse the deficit of an important group of medicines is to prioritize financing, at least one drug per pharmacological group and that the health system always has a therapeutic alternative.
 
The vital medicines destined to the severe and hospitalized care programs, Oncology, Maternal and Child, HIV-AIDS, the treatment of chronic diseases (control cards) and ambulatory use of high demand are also prioritized, she said.
 
She explained that of the 801 drugs in the basic drug list this year, 505 are produced by the national industry and 296 imported, as well as 144 natural products that are available in the National Health System (SNS).
 
The official said that most of the resources are purchased in China, India and in European countries, and clarified that the raw materials and packaging materials are mostly imported.

Share this news

Enviar por E-mail

  • Los comentarios deben basarse en el respeto a los criterios.
  • No se admitirán ofensas, frases vulgares, ni palabras obscenas.
  • Nos reservamos el derecho de no publicar los que incumplan con las normas de este sitio.